Evaluation of the add on effect of <i>Majoone Sarkhas</i> with levothyroxine in primary hypothyroidism: a randomized standard control adjuvant clinical study
The change in thyroid function profiles among adjuvant group, receiving MS with LT in primary hypothyroidism was both clinically and statistically significant. The safety parameters those were followed by serum level of ALT, AST, blood urea and serum creatinine were within the range, indicating the MS is safe medication to be used as an adjuvant therapy with LT (Clinical Trial Registration Code: CTRI/2018/02/011962).
Authors
- Md Anzar Alam (ORCID: https://orcid.org/0000-0002-3548-8873)
- Nafis Haider (ORCID: https://orcid.org/0000-0002-3499-8986)
- Mohd Aleemuddin Quamri (ORCID: https://orcid.org/0000-0002-2695-2582)
- Ghulamuddin Sofi
Institutions
- Jamia Hamdard (IN)
- King Fahd Military Medical Complex (SA)
- Regional Research Institute of Unani Medicine (IN)
- Prince Sultan Military College of Health Sciences
Publication Details
- Journal
- Drug Metabolism and Personalized Therapy
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1515/dmpt-2024-0096
- Citations
- 2
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.59